npj Cardiovascular HealthBioengineeringPeer-reviewed journal article
Characterizing lipoprotein profiles in coronary atherosclerosis development through quantitative lipidomics and proteomics approaches
Hiroaki TakedaiD, Yoshihiro IzumiiD, Yui KoikeiD, Tomonari KoikeiD, Kohta NakataniiD, Kosuke HataiD, Masaki MatsumotoiD, Masashi ShiomiiD, Takeshi BambaiD
Abstract
Lipoproteins, which are synthesized in hepatic cells and secreted into the blood, play an important role in lipid transport. The quality of lipoproteins, including small dense low-density lipoproteins and the cholesterol efflux capacity of high-density lipoproteins, influences cardiovascular outcomes, although the relationship between lipid changes and lipoprotein quality remains unclear. This study characterized lipid molecules and apolipoproteins in lipoprotein particles during the development of coronary atherosclerosis in myocardial infarction-prone rabbits. Using quantitative lipidomics and proteomics techniques, the lipid composition in lipoprotein particles was evaluated by normalizing lipidomics data with lipoprotein particle numbers estimated by apolipoprotein B-100 concentration. While apolipoproteins and common risk factors for abnormal lipid metabolism, including cholesterol and triacylglycerol, did not change across stages of coronary atherosclerosis, ceramide molecules in lipoprotein particles were significantly associated with early stage progression. This study provides a perspective on the role of lipid composition in the progression of coronary atherosclerosis.
- organism: rat
- assay: proteomics
- assay: metabolomics
- research focus: cell type annotation
- approach: experimental assay
- Citations
- 5
- FWCI
- 4.74
- Field percentile
- top 4%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Nanoparticle-enabled plasma proteomics of a mouse atherosclerosis model
Constance Delwarde, Joan T. Matamalas, … Sasha A. Singh·bioRxiv·Aug 1, 2025
- A lipid atlas of human carotid atherosclerosis
A. M. Moerman, M. Visscher, … G. Van Soest·bioRxiv·Mar 9, 2020
- Proteomic and Kinetic Analyses Reveal Discordant Apolipoprotein Turnover and Support a Revised Model of Human Lipoprotein(a) Metabolism
Tiffany Thomas, Anastasiya Matveyenko, … Gissette Reyes‐Soffer·bioRxiv·Sep 9, 2026
- Lzp Ablation Ameliorates Dyslipidemia and Suppresses Atherosclerosis by Reducing Circulating Apolipoprotein B-Containing Lipoproteins
Kunyan He, Xin Ku, … Ze‐Guang Han·bioRxiv·Sep 24, 2025
- Increased atherosclerosis and expression of inflammarafts in macrophage foam cells in AIBP-deficient mice
Shenglin Li, Nicolaus Nazarenkov, … Yury I. Miller·Scientific ReportsPeer-reviewed·Feb 7, 2026
- MicroRNA-541-3p alters lipoproteins to reduce atherosclerosis by degrading Znf101 and Casz1 transcription factors
A. Ansari, P. K. Yadav, … M. M. Hussain·bioRxiv·Nov 1, 2023